Statins drug delivery systems in the treatment of periodontitis: a literature review

Sistemas de administración de estatinas en el tratamiento de la periodontitis: una revisión de literatura

dc.creatorCárdenas Gutiérrez, Angélica María
dc.creatorFernández, Alejandra
dc.creatorPieschacón, María Paulina
dc.creatorNavarro, Gonzalo
dc.date.accessioned2019-09-20T15:37:41Z
dc.date.accessioned2022-09-28T14:14:00Z
dc.date.available2019-09-20T15:37:41Z
dc.date.available2022-09-28T14:14:00Z
dc.date.created2019-09-20T15:37:41Z
dc.identifierhttp://hdl.handle.net/11634/18787
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3655513
dc.languagespa
dc.publisherUniversidad Santo Tomás Seccional Bucaramanga
dc.relationhttp://revistas.ustabuca.edu.co/index.php/USTASALUD_ODONTOLOGIA/article/view/2186/1677
dc.relation/*ref*/Tonetti M, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. J Clin Periodontol. 2017;44(5):456-462. DOI:10.1111/jcpe.12732.
dc.relation/*ref*/Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44. DOI: 10.1038/nri3785.
dc.relation/*ref*/Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res. 2010;89(12):1349-63. DOI:10.1177/0022034510376402.
dc.relation/*ref*/Hajishengallis G. Korostoff J. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000. 2017;75(1):116-151. DOI:10.1111/prd.12181.
dc.relation/*ref*/Chen XT, Chen LL, Tan JY, Shi DH, Ke T, Lei LH. Th17 and Th1 Lymphocytes Are Correlated with Chronic Periodontitis. Immunol Invest. 2016;45(3):243-54. DOI:10.3109/08820139.2016.1138967.
dc.relation/*ref*/Estanislau IM, Terceiro IR, Lisboa MR, Teles P, Carvalho R, Martins R, Moreira M. Effects of statins on the treatment of chronic periodontitis – a systematic review. J Clin Pharmacol. 2015;79(6):877-885. DOI: 10.1111/bcp.12564.
dc.relation/*ref*/Gmiterek A, Kłopot A, Wójtowicz H, Trindade SC, Olczak M, Olczak T. Immune response of macrophages induced by Porphyromonas gingivalis requires HmuY protein. Immunobiology. 2016;221(12):1382-1394. DOI:10.1016/j.imbio.
dc.relation/*ref*/Trombelli L, Farina R, Silva C, Tatakis DN. Plaque-induced gingivitis: case definition and diagnostic considerations. J Clin Periodontol. 2018;89:S46-S73. DOI:10.1002/JPER.17-0576.
dc.relation/*ref*/Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8 Suppl): 1544-1551. DOI:10.1902/jop.2008.080249.
dc.relation/*ref*/Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement forhealthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.
dc.relation/*ref*/Chee B, Park B, Bartold M. Periodontitis and type II diabetes: a two way relationship. Int J Based Healthc. 2013;11(4):317-29. DOI:10.1111/1744-1609.12038.
dc.relation/*ref*/García R, Henshaw M, Krall E. Relationship between Periodontal disease and systemic health. Periodontol 2000. 2001;25:21-36.
dc.relation/*ref*/Otomo-Corgel J, Pucher JJ, Rethman MP, Reynolds MA. State of the science: chronic periodontitis and systemic health. J Evid Based Dent Pract. 2012;12(3 Suppl):20-8. DOI:10.1016/S1532-3382(12)70006-4.
dc.relation/*ref*/Azarpazhooh A, Tenenbaum HC. Separating fact from fiction: use of high-level evidence from research syntheses to identify diseases and disorders associated with periodontal disease. J Can Dent Assoc. 2012;78:c25.
dc.relation/*ref*/Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol. 2003;30(12):1046-52. DOI:10.1046/j.0303-6979.2003.00425.x.
dc.relation/*ref*/Smiley CJ, Tracy SL, Abt E, Michalowicz BS, John MT, Gunsolley J, Cobb CM. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):525-35. DOI:10.1016/j.adaj.2015.01.026.
dc.relation/*ref*/Tvaryanas A, Wagner J, Maupin G. Statins and musculoskeletal conditions in U.S. Air Force Active Duty Aviators. Aerosp Med Hum Perform. 2018;89(5):421-427. DOI:10.7205/MILMED-D-17-00058.
dc.relation/*ref*/Gunjiganur VG, Emani S, Mehta DS, Bhandari S. Effect of 1.2% of simvastatin gel as a local drug delivery system on gingival crevicular fluid interleukin-6 and interleukin-8 levels in non-surgical treatment of chronic periodontitis patients. Archives of Oral Biology. 2017;82:55-61. DOI:10.1016/j.archoralbio.2017.05.022.
dc.relation/*ref*/Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5(4):378-387.
dc.relation/*ref*/Cicek Ari V, Ilarslan YD, Erman B, Sarkarati B, Tezcan I, Karabulut E. Statins and IL-1β, IL-10, and MPO Levels in Gingival Crevicular Fluid: Preliminary Results. Inflammation. 2016;39(4):1547-57. DOI:10.1007/s10753-016-0390-7.
dc.relation/*ref*/Shah M, Muley P, Muley A. Are statins worthy for treatment of periodontitis? A systematic review and meta-analysis. Adv Hum Biol. 2017;7:8-14.
dc.relation/*ref*/Chen L, Nakano K, Kimura S, Matoba T, Iwata E, Miyagawa M, et al. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension. Hypertension. 2011;57(2):343-50. DOI:10.1161/HYPERTENSIONAHA.110.157032.
dc.relation/*ref*/Kim YC, Kim KK, Shevach EM. Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction. Immunology. 2010; 130(4):484-93. DOI:10.1111/j.1365-2567.2010.03269.x.
dc.relation/*ref*/Jin J, Machado E, Yu H, Zhang X, Lu Z, Li Y, Lopes-Virella M, et al. Simvastatin Inhibits LPS-induced Alveolar Bone Loss during Metabolic Syndrome. J Dent Res 2014;93(3):294-9. DOI:10.1177/0022034513516980.
dc.relation/*ref*/Meisel P, Kroemer HK, Nauck M, Holtfreter B, Kocher T. Tooth loss, periodontitis, and statins in a population-based follow-up study. J Periodontol. 2014;85(6):e160-8. DOI:10.1902/jop.2013.130456.
dc.relation/*ref*/Emani S, Gunjiganur GV, Mehta DS. Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An in vitro study. Contemp Clin Dent 2014;5(3):377-82. DOI:10.4103/0976-237X.137959.
dc.relation/*ref*/Thompson P, Clarkson P, Karas RH. Statin-Associated Myopathy. JAMA. 2003;289(13):1681-90.
dc.relation/*ref*/Suresh S, Narayana S, ayakumar P, Sudhakar U, Pramod V. Evaluation of anti-inflammatory effect of statins in chronic periodontitis. Indian J Pharmacol. 2013; 45(4):391-4. DOI:10.4103/0253-7613.115017.
dc.relation/*ref*/Sangwan A, Tewari S, Singh H, Sharma RK, Narula SC Periodontal status and hyperlipidemia: statin users versus non-users. J Periodontol. 2013;84(1):3-12. DOI: 10.1902/jop.2012.110756.
dc.relation/*ref*/Fentoğlu O, Sözen T, Oz SG, Kale B, Sönmez Y, Tonguç MO, et al. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment. Oral Dis. 2010;16(7):648-54. DOI:10.1111/j.1601-0825.2010.01668.x.
dc.relation/*ref*/Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin use and tooth loss in chronic periodontitis patients. J Periodontol. 2006;77(6):1061-6.
dc.relation/*ref*/Elavarasu S, Suthanthiran TK, Naveen D. Statins: A new era in local drug delivery. Journal of Pharmacy & Bioallied Sciences. 2012;4(Suppl 2):S248-51. DOI:10.4103/0975-7406.100225.
dc.relation/*ref*/Morris M, Lee Y, Lavin, M, Giannini P, Schmid, M., Marx D, et al. Injectable simvastatin in periodontal defects and alveolar ridges: pilot studies. Journal of Periodontology. 2008;79(8):1465-73. DOI:10.1902/jop.2008.070659.
dc.relation/*ref*/Fajardo ME, Rocha ML, Sánchez‐Marin FJ, Espinosa‐Chávez EJ. Effect of atorvastatin on chronic periodontitis: a randomized pilot study. J Clin Periodontol 2010;37(11):1016-22. DOI:10.1111/j.1600-051X.2010.01619.x.
dc.relation/*ref*/Seto H, Ohba H, Tokunaga K., Hama H., Horibe M, Nagata, T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res. 2008;43(3):261-7. DOI:10.1111/j.1600-0765.2007.01024.x.
dc.relation/*ref*/Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286(5446):1946-9.
dc.relation/*ref*/Price U, Le HO, Powell SE, Schmid MJ, Marx DB, Zhang Y, et al. Effects of local simvastatin–alendronate conjugate in preventing periodontitis bone loss. J Periodontal Res. 2013;48(5):541-8. DOI:10.1111/jre.12036.
dc.relation/*ref*/Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. J Periodontol. 2010;81(2):214-22. DOI:10.1902/jop.2009.090429.
dc.relation/*ref*/Garg S, Pradeep AR. 1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial. J Periodontol. 2017;88(3):259-265. DOI: 10.1902/jop.2016.160399.
dc.relation/*ref*/Oryan A, Kamali A, Mosh A. Potential mechanisms and applications of statins on osteogenesis: Current modalities, conflicts and future directions. J Control Release. 2015;215:12-24. DOI:10.1016/j.jconrel.2015.07.022.
dc.relation/*ref*/Rao N, Pradeep A, Bajaj P, Kumari M, Naik S. Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial. Aus Dent J. 2013;58 (2):156-62. DOI:10.1111/adj.12042.
dc.relation/*ref*/Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan N, Khojasteh A, Mashhadi-Abbas F, Eslami B, et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats. J Periodontol. 2007;78(8):1561-7.
dc.relation/*ref*/Stein S, Dean IN, Rawal SY, Tipton DA. Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. J Periodontal Res. 2011;46(4):483-90. DOI:10.1111/j.1600-0765.2011.01364.x.
dc.relation/*ref*/Grover H, Luthra S, Maroo S, Maroo N. The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics? Dent Res J (Isfahan). 2013;10(2):143-8.
dc.relation/*ref*/Kamio K, Liu X, Sugiura H, Togo S, Kawasaki S, Wang X, et al. Statins inhibit matrix metalloproteinase release from human lung fibroblasts. Eur Respir J. 2010;35(3):637-46. DOI:10.1183/09031936.00134707.
dc.relation/*ref*/Gursoy UK, Könönen E, Huumonen S, Tervahartiala T, Pussinen PJ, Suominen AL, et al. Salivary type I collagen degradation end-products and related matrixmetalloproteinases in periodontitis. J Clin Periodontol 2013;40(1):18-25. DOI:10.1111/jcpe.12020.
dc.relation/*ref*/Koga J, Matoba T, Egashira K. Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases. J Atheroscler Thromb. 2016;23(7):757-65. DOI:10.5551/jat.35113.
dc.relation/*ref*/Wu Y, Wang Z, Liu G, Zeng X, Wang X, Gao Y, et al. Novel Simvastatin-Loaded Nanoparticles Based on Cholic Acid-Core Star-Shaped PLGA for Breast Cancer Treatment. J Biomed Nanotechnol. 2015;11(7):1247-60.
dc.relation/*ref*/Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice. Int J Nanomedicine. 2016;11:885-904. DOI:10.2147/IJN.S88546.
dc.relation/*ref*/Tiwari R, Pathak K. Statins therapy: a review on conventional and novel formulation approaches. J Pharm Pharmacol. 2011;63(8):983-98. DOI:10.1111/j.2042-7158.2011.01273.x.
dc.relation/*ref*/Garrett IR, Gutierrez GE, Rossini G, Nyman J, McCluskey B, Flores A, et al. Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J Orthop Res. 2007;25(10):1351-7.
dc.rightsCopyright (c) 2019 UstaSalud
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.sourceUstaSalud; Vol. 17 (2018); 40-47
dc.source1692-5106
dc.titleStatins drug delivery systems in the treatment of periodontitis: a literature review
dc.titleSistemas de administración de estatinas en el tratamiento de la periodontitis: una revisión de literatura
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtículo revisado por pares


Este ítem pertenece a la siguiente institución